These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 23897183

  • 1. Treatment by long haemodialysis sessions with high cut-off filters in myeloma cast nephropathy: our experience.
    Borrego-Hinojosa J, Pérez-del Barrio MP, Biechy-Baldan Mdel M, Merino-García E, Sánchez-Perales MC, García-Cortés MJ, Ocaña-Pérez E, Gutiérrez-Rivas P, Liébana-Cañada A.
    Nefrologia; 2013; 33(4):515-23. PubMed ID: 23897183
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Management options for cast nephropathy in multiple myeloma.
    Cockwell P, Hutchison CA.
    Curr Opin Nephrol Hypertens; 2010 Nov; 19(6):550-5. PubMed ID: 20827195
    [Abstract] [Full Text] [Related]

  • 6. Effectiveness of IHD with Adsorptive PMMA Membrane in Myeloma Cast Nephropathy: A Cohort Study.
    Sens F, Chaintreuil D, Jolivot A, Guebre-Egziabher F, Robinson P, Karlin L, Bridoux F, Juillard L.
    Am J Nephrol; 2017 Nov; 46(5):355-363. PubMed ID: 29017155
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of blood purification and bortezomib plus dexamethasone therapy for the treatment of acute renal failure due to myeloma cast nephropathy.
    Hasegawa M, Kondo F, Yamamoto K, Murakami K, Tomita M, Nabeshima K, Nakai S, Kato M, Ohashi A, Arai J, Hiki Y, Ishii J, Emi N, Sugiyama S, Yuzawa Y.
    Ther Apher Dial; 2010 Oct; 14(5):451-6. PubMed ID: 21175542
    [Abstract] [Full Text] [Related]

  • 8. Extended high cut-off haemodialysis for myeloma cast nephropathy in Auckland, 2008-2012.
    Tan J, Lam-Po-Tang M, Hutchison CA, de Zoysa JR.
    Nephrology (Carlton); 2014 Jul; 19(7):432-5. PubMed ID: 24931113
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cast nephropathy with acute renal failure treated with high cut-off haemodialysis in a patient with multiple myeloma.
    Shum HP, Chan KC, Chow CC, Kho BC, Yan WW.
    Hong Kong Med J; 2010 Dec; 16(6):489-92. PubMed ID: 21135429
    [Abstract] [Full Text] [Related]

  • 11. Effectiveness of Haemodiafiltration with Heat Sterilized High-Flux Polyphenylene HF Dialyzer in Reducing Free Light Chains in Patients with Myeloma Cast Nephropathy.
    Rousseau-Gagnon M, Agharazii M, De Serres SA, Desmeules S.
    PLoS One; 2015 Dec; 10(10):e0140463. PubMed ID: 26466100
    [Abstract] [Full Text] [Related]

  • 12. Successful use of combined high cut-off haemodialysis and bortezomib for acute kidney injury associated with myeloma cast nephropathy.
    Ward F, Dunne O, Crotty TB, Fennelly D, Watson A, Holian J.
    Ir Med J; 2012 May; 105(5):148-9. PubMed ID: 22803494
    [Abstract] [Full Text] [Related]

  • 13. Treatment of acute kidney injury with cast nephropathy.
    Walther C, Podoll AS, Finkel KW.
    Clin Nephrol; 2014 Jul; 82(1):1-6. PubMed ID: 24725380
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Impact of free light chain hemodialysis in myeloma cast nephropathy: a case-control study.
    Peters NO, Laurain E, Cridlig J, Hulin C, Cao-Huu T, Frimat L.
    Hemodial Int; 2011 Oct; 15(4):538-45. PubMed ID: 22111823
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Aggregated serum free light chains may prevent adequate removal by high cut-off haemodialysis.
    Harding S, Provot F, Beuscart JB, Cook M, Bradwell AR, Stringer S, White D, Cockwell P, Hutchison CA.
    Nephrol Dial Transplant; 2011 Apr; 26(4):1438. PubMed ID: 21406545
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The rationale and evidence base for the direct removal of serum-free light chains in the management of myeloma kidney.
    Cockwell P, Cook M.
    Adv Chronic Kidney Dis; 2012 Sep; 19(5):324-32. PubMed ID: 22920643
    [Abstract] [Full Text] [Related]

  • 20. Effectiveness of haemodiafiltration with ultrafiltrate regeneration in the reduction of light chains in multiple myeloma with renal failure.
    Pendón-Ruiz de Mier MV, Alvarez-Lara MA, Ojeda-López R, Martín-Malo A, Carracedo J, Caballero-Villarraso J, Alonso C, Aljama P.
    Nefrologia; 2013 Nov 13; 33(6):788-96. PubMed ID: 24241366
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.